Table 1 Clinic characteristics of type 2 diabetic patients with or without PAD
NPAD (N = 940) | PAD (N = 78) | P | |
|---|---|---|---|
Age, years | 57.82 ± 11.12 | 67.88 ± 9.77 | 0.000 |
Male, n(%) | 526 (56.0%) | 38 (48.7%) | 0.216 |
BMI, kg/m2 | 25.58 ± 3.36 | 26.08 ± 3.62 | 0.204 |
Smoking status, n(%) | |||
never | 589 (62.7%) | 45 (55.7%) | |
former | 105 (11.2%) | 15 (19.2%) | 0.104 |
current | 246 (26.2%) | 18 (23.1%) | |
Duration of diabetes | |||
≥10 years | 565 (60.1%) | 57 (73.1%) | 0.024 |
<10 years | 375 (39.9%) | 21 (26.9%) | |
Hypertension, n(%) | 525 (55.9%) | 62 (79.5%) | 0.000 |
Hyperlipidemia, n (%) | 505 (53.7%) | 46 (59.0%) | 0.371 |
CHD, n (%) | 201 (21.4%) | 37 (47.4%) | 0.000 |
Cerebral infarction, n (%) | 119 (12.7%) | 20 (25.6%) | 0.001 |
Diabetic retinopathy, n (%) | |||
NDR | 665 (70.7%) | 39 (50.0%) | |
NPDR | 171 (18.2%) | 24 (30.8%) | 0.001 |
PDR | 104 (11.1%) | 15 (19.2%) | |
GFR, ml/min | 92.22 ± 19.92 | 75.33 ± 19.90 | 0.000 |
HbA1c, % | 8.77 ± 1.82 | 9.12 ± 1.71 | 0.108 |
Serum creatinine, umol/L | 65.34 ± 15.17 | 72.77 ± 17.97 | 0.001 |
Serum uric acid, mmol/L | 329.92 ± 79.93 | 340.85 ± 82.75 | 0.253 |
TC, mmol/L | 4.47 ± 0.99 | 4.55 ± 1.17 | 0.488 |
LDL, mmol/L | 2.68 ± 0.84 | 2.74 ± 0.97 | 0.598 |
HDL, mmol/L | 1.20 ± 0.31 | 1.02 ± 0.27 | 0.712 |
TG, mmol/L | 1.85 ± 1.57 | 1.96 ± 1.23 | 0.537 |
Serum 25(OH)D, ng/ml | 14.81 ± 8.43 | 11.55 ± 5.65 | 0.000 |
Serum calcium, mmol/L | 2.25 ± 0.09 | 2.26 ± 0.10 | 0.412 |
Serum phosphate, mmol/L | 1.26 ± 0.17 | 1.24 ± 0.16 | 0.314 |
ALP, mmol/L | 73.42 ± 22.2 | 73.35 ± 23.33 | 0.978 |